<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr Virus (EBV) is implicated in the pathogenesis of endemic Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>), B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> occurring under immunosuppression, nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp> and <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Two distinct patterns of latent EBV gene expression occur in EBV-associated <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BLs</z:e> typically display expression of the nuclear antigen EBNAI only, whereas EBV-associated, non-Burkitt B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> express at least 9 latent <z:mp ids='MP_0001799'>viral</z:mp> genes (6 EBNAs and 3 latent membrane proteins), reminiscent of in vitro EBV-immortalized lymphoblastoid cell lines (LCL) </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BLs</z:e> are characterized by local, extra-nodal growth, whereas EBV-associated B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> often disseminate to peripheral lymphoid tissue </plain></SENT>
<SENT sid="4" pm="."><plain>We show here that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells forming local <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> after xenotransplantation into <z:mp ids='MP_0002536'>SCID</z:mp> mice disseminate to lymphoid tissue following introduction of the latent membrane protein I (LMP 1) gene </plain></SENT>
<SENT sid="5" pm="."><plain>Introduction of LMP 1 into <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells induced expression of CD44 on the cell surface, a molecule implicated in enhanced <z:mp ids='MP_0002022'>lymphoid tumor</z:mp> growth and dissemination </plain></SENT>
<SENT sid="6" pm="."><plain>Introduction of CD44 into LMP 1-/CD44-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells was observed to confer the disseminated <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> pattern associated with LMP 1 expression </plain></SENT>
<SENT sid="7" pm="."><plain>Taken together our results show that expression of LMP 1 may regulate expression of CD44 and play an important role in the behavior of EBV-based <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
</text></document>